13 results
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:17pm
of attrition from the failure of product candidates proceeding through preclinical studies and clinical trials. Positive or timely results from
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:11pm
population than we originally requested.
There is typically an extremely high rate of attrition from the failure of product candidates proceeding through
424B5
xa4c1yib43zv2wyha
8 May 23
Prospectus supplement for primary offering
5:19pm
424B5
o7mnpq1s1bv63cj3h
8 May 23
Prospectus supplement for primary offering
5:18pm
424B5
yv8wbpknkz6xyb
9 Nov 22
Prospectus supplement for primary offering
4:29pm
10-Q
274k358sgb0ym1430
8 Nov 22
Quarterly report
4:09pm
424B5
xgyaq77gz62uns9v8r
21 Oct 22
Prospectus supplement for primary offering
4:16pm
424B5
re26krprkm
13 Oct 22
Prospectus supplement for primary offering
4:56pm
- Prev
- 1
- Next